Background Image

Opportunities To Collaborate

Working together for a greater cause

Let's get started

Business Development

Building on its legacy of innovations in drug delivery systems and treatments in Pain Management, Mundipharma is committed to direct its efforts in bringing to market innovative products to meet patient needs.
Mundipharma is one of the fastest growing pharmaceutical enterprises in the Emerging markets. This growth is supported by a heavy R&D focus on new product development that challenges orthodoxies to improve quality of life for people everywhere. Over its history of more than 60 years, Mundipharma has established its presence across six continents, with production facilities in US, UK, China, Canada, Germany and Cyprus

Rapid Growth
Mundipharma is one of the fastest growing pharmaceutical enterprises in the market.
Innovative Solutions
This growth is supported by a heavy R&D focus on new product development that challenges orthodoxies to improve quality of life for people everywhere.
Global Prescence
Over its history of more than 60 years, Mundipharma has established its presence across six continents, with production facilities in US, UK, China, Canada, Germany and Cyprus.
Worldwide Support
Mundipharma’s treatments provide support to more than four billion patients worldwide.

OUR COMMITMENT TO THE MEA REGION

We at Mundipharma are committed to serving patients in the MEA region, by identifying unmet needs and investing in bringing to market treatments that do not reach patients owing to the complexities in conducting business in this diverse yet interesting region. Mundipharma’s history of operating in the region for over 3 decades along with a leadership team that has spent significant time in the region, has allowed us to establish a solid network among all stakeholders in the healthcare system.

WHAT WE SEEK

Mundipharma is actively pursuing opportunities to

  • Expand its current portfolio in Pain Management, Oncology, Respiratory, Consumer Healthcare and Ophthalmology.
  • Expand into adjunct therapy areas where treatments are currently unavailable in the Middle East, Africa and Pakistan.

Background Image

Who are our
ideal partners

At Mundipharma, we put patients first and hence our ideal partners are companies that have products that could revolutionize patient care and meet unmet needs of patients in the region. We are open to opportunities relating to products that are in market or at development stage.

What we offer in return is the commitment of ensuring their products reach its highest commercial potential. As a privately held company, Mundipharma is in a unique position to engage in innovative partnership models including but not limited to in-licensing, exclusive sales and promotion, asset acquisitions etc.

Please contact us to explore collaboration opportunities.

Contact us to explore
collaboration opportunities

↓
WordPress Video Lightbox Plugin